Kiora Pharmaceuticals (KPRX) Misses Q2 EPS by 53c

Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.53).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick